retatrutide clinical trial results 2024 2025 press release eli lilly may become one of the most important longevity-related What Is Retatrutide? Side Effects,

Going below these levels accelerates muscle loss, triggers hair loss, impairs immune function, and slows metabolic rate

The medication cannot be stopped, since most studies have shown weight regain when the patient stops using it

Semaglutide targets only GLP-1 receptors

Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor

Table of Contents: How does Semaglutide GLP-1 help with weight loss and appetite control

Prior authorization is required for GLP-1 medications to ensure that they are medically necessary and that the insurance company is covering treatments that align with their approved guidelines